ImmunoCellular Therapeutics Announces Agreement on Terms of Settlement of Federal Class Action Shareholder Lawsuit investors.imuc.com/press-releases $IMUC

ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results ow.ly/ypGj30lo7yi $IMUC

ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants investors.imuc.com/news-releases/… $IMUC

ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future Strategy ow.ly/BsNo30eDaLs $IMUC

Today 5pm EDT, ImmunoCellular Business Update on Research & Development & Future Strategy. Webcast: ow.ly/8DG430eDdKk $IMUC

ImmunoCellular Therapeutics Announces NYSE MKT Acceptance of its Plan of Compliance ow.ly/KeqE30f8uAn $IMUC

ImmunoCellular Therapeutics to Present at the Lytham Partners Virtual Investor Conference on October 11 ow.ly/TMSn30fAZlb $IMUC

Today 2pm EDT ImmunoCellular to present at Lytham Partners Virtual Investor Conference. Webcast and info: ow.ly/izEe30fMD0B $IMUC

ImmunoCellular Therapeutics to Report Third Quarter 2017 Financial Results on November 21, 2017 ow.ly/B5e530gDCji $IMUC

ImmunoCellular Therapeutics Announces Third Quarter 2017 Financial Results. Conference call and webcast today ow.ly/ACF030gJrpf $IMUC

Conference call and webcast 5pm EST today - 3Q Financial results and business update ow.ly/vrGK30gJrXH $IMUC

ImmunoCellular Therapeutics to Present at the 10th Annual LD Micro Main Event on December 7, 2017 ow.ly/xjUH30gK4Wo $IMUC

Next week Dec 7, 2017 ImmunoCellular Therapeutics to Present at LD Micro Main Event ow.ly/ZA8M30gK571 $IMUC

ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program ow.ly/kdXb30hcYwz $IMUC

ImmunoCellular Therapeutics Announces Update on Financial Condition ow.ly/S1yO30imZZi $IMUC

ImmunoCellular Therapeutics Announces Review of Strategic Alternatives ow.ly/rxu330ixQrp $IMUC

ImmunoCellular Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018 ow.ly/UKO630iNAEV $IMUC

ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results investors.imuc.com/releasedetail.… $IMUC

ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program ow.ly/Rdwn30jrXrh $IMUC

ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results investors.imuc.com/releases.cfm $IMUC